Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Van Landingham

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Annals of the New York Academy of Sciences|February 17, 2000
Estimates of the proportions of carcinogens and anticarcinogens in bioassays conducted by the U.S. National Toxicology Program. Application of a new meta-analytic approachK S Crump, D Krewski, C Van Landingham
Environmental Health Perspectives|January 5, 1999
Estimates of the proportion of chemicals that were carcinogenic or anticarcinogenic in bioassays conducted by the National Toxicology ProgramK S Crump, D Krewski, C Van Landingham
Regulatory Toxicology and Pharmacology : RTP|October 24, 1998
Calculation of benchmark doses for reproductive and developmental toxicity observed after exposure to isopropanolB Allen, R Gentry, A Shipp, et al.
Toxicology Letters|May 20, 2017
A global human health risk assessment for octamethylcyclotetrasiloxane (D<sub>4</sub>)Robinan Gentry, Allison Franzen, C Van Landingham, et al.
Environmental Research|March 22, 2020
Objective ranges of soil-to-dust transfer coefficients for lead-impacted sitesJ W Tu, W Fuller, A M Feldpausch, et al.
Frontiers in Pharmacology|September 4, 2023
Using available <i>in vitro</i> metabolite identification and time course kinetics for β-chloroprene and its metabolite, (1-chloroethenyl) oxirane, to include reactive oxidative metabolites and glutathione depletion in a PBPK model for β-chloropreneJ L Campbell, H J Clewell, C Van Landingham, et al.
Environmental Health Perspectives|March 8, 2000
Benchmark concentrations for methylmercury obtained from the Seychelles Child Development StudyK S Crump, C Van Landingham, C Shamlaye, et al.
Toxicology and Industrial Health|January 5, 2002
Determination of a site-specific reference dose for methylmercury for fish-eating populationsA M Shipp, P R Gentry, G Lawrence, et al.
Critical Reviews in Toxicology|September 16, 2006
Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effectsA Shipp, G Lawrence, R Gentry, et al.
Regulatory Toxicology and Pharmacology : RTP|July 11, 2014
A constrained maximum likelihood approach to evaluate the impact of dose metric on cancer risk assessment: application to β-chloropreneB C Allen, C Van Landingham, Y Yang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annals of the New York Academy of Sciences|February 17, 2000
Estimates of the proportions of carcinogens and anticarcinogens in bioassays conducted by the U.S. National Toxicology Program. Application of a new meta-analytic approachK S Crump, D Krewski, C Van Landingham
Environmental Health Perspectives|January 5, 1999
Estimates of the proportion of chemicals that were carcinogenic or anticarcinogenic in bioassays conducted by the National Toxicology ProgramK S Crump, D Krewski, C Van Landingham
Regulatory Toxicology and Pharmacology : RTP|October 24, 1998
Calculation of benchmark doses for reproductive and developmental toxicity observed after exposure to isopropanolB Allen, R Gentry, A Shipp, et al.
Toxicology Letters|May 20, 2017
A global human health risk assessment for octamethylcyclotetrasiloxane (D<sub>4</sub>)Robinan Gentry, Allison Franzen, C Van Landingham, et al.
Environmental Research|March 22, 2020
Objective ranges of soil-to-dust transfer coefficients for lead-impacted sitesJ W Tu, W Fuller, A M Feldpausch, et al.
Frontiers in Pharmacology|September 4, 2023
Using available <i>in vitro</i> metabolite identification and time course kinetics for β-chloroprene and its metabolite, (1-chloroethenyl) oxirane, to include reactive oxidative metabolites and glutathione depletion in a PBPK model for β-chloropreneJ L Campbell, H J Clewell, C Van Landingham, et al.
Environmental Health Perspectives|March 8, 2000
Benchmark concentrations for methylmercury obtained from the Seychelles Child Development StudyK S Crump, C Van Landingham, C Shamlaye, et al.
Toxicology and Industrial Health|January 5, 2002
Determination of a site-specific reference dose for methylmercury for fish-eating populationsA M Shipp, P R Gentry, G Lawrence, et al.
Critical Reviews in Toxicology|September 16, 2006
Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effectsA Shipp, G Lawrence, R Gentry, et al.
Regulatory Toxicology and Pharmacology : RTP|July 11, 2014
A constrained maximum likelihood approach to evaluate the impact of dose metric on cancer risk assessment: application to β-chloropreneB C Allen, C Van Landingham, Y Yang, et al.
Pageof 1